697 filings
10-K/A
2023 FY
ACORQ
Acorda Therapeutics Inc
Annual report (amended)
29 Apr 24
8:39am
8-K
ACORQ
Acorda Therapeutics Inc
25 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00pm
25-NSE
The Nasdaq Stock Market LLC
25 Apr 24
Exchange delisting
9:10am
8-K
ACORQ
Acorda Therapeutics Inc
17 Apr 24
Acorda Therapeutics Announces Delisting from Nasdaq
9:10am
8-K
ACORQ
Acorda Therapeutics Inc
1 Apr 24
Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
8:12pm
8-K
6t4jjmpx2
13 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
uvroki
11 Jan 24
Termination of a Material Definitive Agreement
8:33am
8-K
bz2hyxmbz
1 Dec 23
Other Events
4:30pm
8-K
wie9uhv 57e77szh
13 Nov 23
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
4:16pm
8-K
ik765 34jjqlw6
8 Aug 23
Acorda Therapeutics Reports Second Quarter 2023 Financial Results
4:12pm
8-K
ucqip6rh0rm8qk
27 Jun 23
Departure of Directors or Certain Officers
4:35pm
8-K
gjemtli
26 Jun 23
Other Events
4:30pm
8-K
nnys iepuj4kfnk5
2 Jun 23
Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split
4:28pm
8-K
pknhdquhm 3d7c7p
1 Jun 23
Other Events
5:17pm
8-K
qeojtcu3sosg
31 May 23
Other Events
5:07pm
8-K
i67fe
11 May 23
Acorda Therapeutics Reports First Quarter 2023 Financial Results
4:15pm